1,678
Views
55
CrossRef citations to date
0
Altmetric
Review

Inhibiting homologous recombination for cancer therapy

, &
Pages 61-68 | Received 20 Sep 2011, Accepted 28 Nov 2011, Published online: 15 Jan 2012

References

  • Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 2008; 8:193 - 204; PMID: 18256616; http://dx.doi.org/10.1038/nrc2342
  • Saleh-Gohari N, Helleday T. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res 2004; 32:3683 - 3688; PMID: 15252152; http://dx.doi.org/10.1093/nar/gkh703
  • Rothkamm K, Kruger I, Thompson LH, Lobrich M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 2003; 23:5706 - 5715; PMID: 12897142; http://dx.doi.org/10.1128/MCB.23.16.5706-5715.2003
  • Aylon Y, Liefshitz B, Kupiec M. The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle. EMBO J 2004; 23:4868 - 4875; PMID: 15549137; http://dx.doi.org/10.1038/sj.emboj.7600469
  • Ira G, Pellicioli A, Balijja A, Wang X, Fiorani S, Carotenuto W, et al. DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1. Nature 2004; 431:1011 - 1017; PMID: 15496928; http://dx.doi.org/10.1038/nature02964
  • Game JC. Spencer JFT, Spencer D, Smith ARW. Radiation-sensitive mutants and repair in yeast. Yeast Genetics, Fundamental and Applied Aspects 1983; New York Springer-Verlag 109 - 137
  • Moynahan ME, Cui TY, Jasin M. Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res 2001; 61:4842 - 4850; PMID: 11406561
  • Evans JW, Chernikova SB, Kachnic LA, Banath JP, Sordet O, Delahoussaye YM, et al. Homologous recombination is the principal pathway for the repair of DNA damage induced by tirapazamine in mammalian cells. Cancer Res 2008; 68:257 - 265; PMID: 18172318; http://dx.doi.org/10.1158/0008-5472.CAN-06-4497
  • Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 2005; 434:913 - 917; PMID: 15829966; http://dx.doi.org/10.1038/nature03443
  • Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005; 434:917 - 921; PMID: 15829967; http://dx.doi.org/10.1038/nature03445
  • Starcevic D, Dalal S, Sweasy JB. Is there a link between DNA polymerase beta and cancer?. Cell Cycle 2004; 3:998 - 1001; PMID: 15280658; http://dx.doi.org/10.4161/cc.3.8.1062
  • Goodarzi AA, Noon AT, Deckbar D, Ziv Y, Shiloh Y, Lobrich M, et al. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell 2008; 31:167 - 177; PMID: 18657500; http://dx.doi.org/10.1016/j.molcel.2008.05.017
  • Beucher A, Birraux J, Tchouandong L, Barton O, Shibata A, Conrad S, et al. ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2. EMBO J 2009; 28:3413 - 3427; PMID: 19779458; http://dx.doi.org/10.1038/emboj.2009.276
  • Sørensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, Bartek J, et al. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol 2005; 7:195 - 201; PMID: 15665856; http://dx.doi.org/10.1038/ncb1212
  • Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, et al. ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 2006; 8:37 - 45; PMID: 16327781; http://dx.doi.org/10.1038/ncb1337
  • Huertas P, Cortes-Ledesma F, Sartori AA, Aguilera A, Jackson SP. CDK targets Sae2 to control DNA-end resection and homologous recombination. Nature 2008; 455:689 - 692; PMID: 18716619; http://dx.doi.org/10.1038/nature07215
  • Moyal L, Lerenthal Y, Gana-Weisz M, Mass G, So S, Wang SY, et al. Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Mol Cell 2011; 41:529 - 542; PMID: 21362549; http://dx.doi.org/10.1016/j.molcel.2011.02.015
  • Chernikova SB, Dorth JA, Razorenova OV, Game JC, Brown JM. Deficiency in Bre1 impairs homologous recombination repair and cell cycle checkpoint response to radiation damage in mammalian cells. Radiat Res 2010; 174:558 - 565; PMID: 20738173; http://dx.doi.org/10.1667/RR2184.1
  • Symington LS, Gautier J. Double-strand break end resection and repair pathway choice. Annu Rev Genet 2011; 45:247 - 271; PMID: 21910633; http://dx.doi.org/10.1146/annurev-genet-110410-132435
  • Moynahan ME, Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 2010; 11:196 - 207; PMID: 20177395; http://dx.doi.org/10.1038/nrm2851
  • San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem 2008; 77:229 - 257; PMID: 18275380; http://dx.doi.org/10.1146/annurev.biochem.77.061306.125255
  • Heyer WD, Ehmsen KT, Liu J. Regulation of homologous recombination in eukaryotes. Annu Rev Genet 2010; 44:113 - 139; PMID: 20690856; http://dx.doi.org/10.1146/annurev-genet-051710-150955
  • Pardo B, Gomez-Gonzalez B, Aguilera A. DNA repair in mammalian cells: DNA double-strand break repair: how to fix a broken relationship. Cell Mol Life Sci 2009; 66:1039 - 1056; PMID: 19153654; http://dx.doi.org/10.1007/s00018-009-8740-3
  • Huertas P, Jackson SP. Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J Biol Chem 2009; 284:9558 - 9565; PMID: 19202191; http://dx.doi.org/10.1074/jbc.M808906200
  • Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res 2008; 18:99 - 113; PMID: 18166982; http://dx.doi.org/10.1038/cr.2008.1
  • Helleday T. Homologous recombination in cancer development, treatment and development of drug resistance. Carcinogenesis 2010; 31:955 - 960; PMID: 20351092; http://dx.doi.org/10.1093/carcin/bgq064
  • Dobzhansky T. Genetics of natural populations; recombination and variability in populations of Drosophila pseudoobscura. Genetics 1946; 31:269 - 290
  • Hartman JL 4th, Garvik B, Hartwell L. Principles for the buffering of genetic variation. Science 2001; 291:1001 - 1004; PMID: 11232561; http://dx.doi.org/10.1126/science.291.5506.1001
  • Nijman SM. Synthetic lethality: general principles, utility and detection using genetic screens in human cells. FEBS Lett 2011; 585:1 - 6; PMID: 21094158; http://dx.doi.org/10.1016/j.febslet.2010.11.024
  • Game JC, Cox BS. Synergistic interactions between rad mutations in yeast. Mutat Res 1973; 20:35 - 44; PMID: 4586553; http://dx.doi.org/10.1016/0027-5107(73)90095-X
  • Friedberg EC. Deoxyribonucleic acid repair in the yeast Saccharomyces cerevisiae. Microbiol Rev 1988; 52:70 - 102; PMID: 3280967
  • Game JC, Mortimer RK. A genetic study of x-ray sensitive mutants in yeast. Mutat Res 1974; 24:281 - 292; PMID: 4606119; http://dx.doi.org/10.1016/0027-5107(74)90176-6
  • Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009; 361:123 - 134; PMID: 19553641; http://dx.doi.org/10.1056/NEJMoa0900212
  • Thompson LH, Brookman KW, Dillehay LE, Carrano AV, Mazrimas JA, Mooney CL, et al. A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister-chromatid exchange. Mutat Res 1982; 95:427 - 440; PMID: 6889677; http://dx.doi.org/10.1016/0027-5107(82)90276-7
  • Oikawa A, Tohda H, Kanai M, Miwa M, Sugimura T. Inhibitors of poly(adenosine diphosphate ribose) polymerase induce sister chromatid exchanges. Biochem Biophys Res Commun 1980; 97:1311 - 1316; PMID: 6260088; http://dx.doi.org/10.1016/S0006-291X(80)80009-X
  • Neijenhuis S, Verwijs-Janssen M, van den Broek LJ, Begg AC, Vens C. Targeted radiosensitization of cells expressing truncated DNA polymerase {beta}. Cancer Res 2010; 70:8706 - 8714; PMID: 20978197; http://dx.doi.org/10.1158/0008-5472.CAN-09-3901
  • Patel AG, Sarkaria JN, Kaufmann SH. Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells. Proc Natl Acad Sci USA 2011; 108:3406 - 3411; PMID: 21300883; http://dx.doi.org/10.1073/pnas.1013715108
  • Feng Z, Scott SP, Bussen W, Sharma GG, Guo G, Pandita TK, et al. Rad52 inactivation is synthetically lethal with BRCA2 deficiency. Proc Natl Acad Sci USA 2011; 108:686 - 691; PMID: 21148102; http://dx.doi.org/10.1073/pnas.1010959107
  • Herrero AB, Martin-Castellanos C, Marco E, Gago F, Moreno S. Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin. Cancer Res 2006; 66:8155 - 8162; PMID: 16912194; http://dx.doi.org/10.1158/0008-5472.CAN-06-0179
  • Noguchi M, Yu D, Hirayama R, Ninomiya Y, Sekine E, Kubota N, et al. Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Biochem Biophys Res Commun 2006; 351:658 - 663; PMID: 17083915; http://dx.doi.org/10.1016/j.bbrc.2006.10.094
  • Choudhury A, Zhao H, Jalali F, Al Rashid S, Ran J, Supiot S, et al. Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity. Mol Cancer Ther 2009; 8:203 - 213; PMID: 19139130; http://dx.doi.org/10.1158/1535-7163.MCT-08-0959
  • Adimoolam S, Sirisawad M, Chen J, Thiemann P, Ford JM, Buggy JJ. HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination. Proc Natl Acad Sci USA 2007; 104:19482 - 19487; PMID: 18042714; http://dx.doi.org/10.1073/pnas.0707828104
  • Shi W, Ma Z, Willers H, Akhtar K, Scott SP, Zhang J, et al. Disassembly of MDC1 foci is controlled by ubiquitin-proteasome-dependent degradation. J Biol Chem 2008; 283:31608 - 31616; PMID: 18757370; http://dx.doi.org/10.1074/jbc.M801082200
  • Murakawa Y, Sonoda E, Barber LJ, Zeng W, Yokomori K, Kimura H, et al. Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cells. Cancer Res 2007; 67:8536 - 8543; PMID: 17875693; http://dx.doi.org/10.1158/0008-5472.CAN-07-1166
  • Dupré A, Boyer-Chatenet L, Sattler RM, Modi AP, Lee JH, Nicolette ML, et al. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol 2008; 4:119 - 125; PMID: 18176557; http://dx.doi.org/10.1038/nchembio.63
  • Flott S, Kwon Y, Pigli YZ, Rice PA, Sung P, Jackson SP. Regulation of Rad51 function by phosphorylation. EMBO Rep 2011; 12:833 - 839; PMID: 21738226; http://dx.doi.org/10.1038/embor.2011.127
  • Peasland A, Wang LZ, Rowling E, Kyle S, Chen T, Hopkins A, et al. Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines. Br J Cancer 2011; 105:372 - 381; PMID: 21730979; http://dx.doi.org/10.1038/bjc.2011.243
  • Morgan MA, Parsels LA, Zhao L, Parsels JD, Davis MA, Hassan MC, et al. Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. Cancer Res 2010; 70:4972 - 4981; PMID: 20501833; http://dx.doi.org/10.1158/0008-5472.CAN-09-3573
  • Johnson N, Cai D, Kennedy RD, Pathania S, Arora M, Li YC, et al. Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage. Mol Cell 2009; 35:327 - 339; PMID: 19683496; http://dx.doi.org/10.1016/j.molcel.2009.06.036
  • Johnson N, Li YC, Walton ZE, Cheng KA, Li D, Rodig SJ, et al. Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition. Nat Med 2011; 17:875 - 882; PMID: 21706030; http://dx.doi.org/10.1038/nm.2377
  • Chirnomas D, Taniguchi T, de la Vega M, Vaidya AP, Vasserman M, Hartman AR, et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol Cancer Ther 2006; 5:952 - 961; PMID: 16648566; http://dx.doi.org/10.1158/1535-7163.MCT-05-0493
  • Huang F, Motlekar NA, Burgwin CM, Napper AD, Diamond SL, Mazin AV. Identification of specific inhibitors of human RAD51 recombinase using high-throughput screening. ACS Chem Biol 2011; 6:628 - 635; PMID: 21428443; http://dx.doi.org/10.1021/cb100428c

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.